Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 USD | -4.68% |
|
-3.56% | -46.52% |
May. 23 | Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment | MT |
May. 23 | Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.97M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.3
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.16% |
Latest transcript on Theriva Biologics, Inc.
1 day | -4.68% | ||
1 week | -3.56% | ||
Current month | -2.67% | ||
1 month | -8.04% | ||
3 months | -47.73% | ||
6 months | -47.85% | ||
Current year | -46.52% |
![Extreme 0.225](/images/extremecours_fleche.png)
![Extreme 0.225](/images/extremecours_fleche.png)
![Extreme 0.225](/images/extremecours_fleche.png)
![Extreme 0.1972](/images/extremecours_fleche.png)
![Extreme 0.1972](/images/extremecours_fleche.png)
![Extreme 0.1972](/images/extremecours_fleche.png)
![Extreme 0.1972](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 0.23 | -4.68% | 78,033 |
24-07-01 | 0.2413 | +2.12% | 72,107 |
24-06-28 | 0.2363 | -2.80% | 201,809 |
24-06-27 | 0.2431 | +2.53% | 82,642 |
24-06-26 | 0.2371 | -0.59% | 76,332 |
Delayed Quote Nyse, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.52% | 3.97M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.66% | 26.22B | |
-25.37% | 19.01B | |
-19.88% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- TOVX Stock